Mylan-Upjohn Merger Leaves Analysts Skeptical

The new merger will bring blockbusters like Mylan’s EpiPen and Upjohn’s Viagra under the same roof. Together, the new company — referred to only as NewCo — will be able to expand its vast product portfolio into unexplored global markets.

“Importantly, the combined organization will have a presence across nearly every continent and major market, establishing a new leadership position in Asia, and offering products capable of treating all major therapeutic areas,” said Robert Coury from Mylan in a statement.